Free lookups: 2/3 Unlock Pro
Clinical reference Find a medicine
Ctrl K
2 of 3 free lookups remaining Upgrade
New search Medicine profile Hydrocortisone / Neomycin ear /eye drop

Clinical medicine profile

Hydrocortisone / Neomycin ear /eye drop

Corticosteroid [EPC]

POM
Evidence state Source-linked Review date not recorded
Route
ORAL / IV / IM / INHALED / TOPICAL / NASAL / OPHTHALMIC
Schedule
POM
ATC
Not assigned
PPB status
registered
Patient advice Check interactions
01 Risk first

Safety essentials

The information most likely to change a prescribing or dispensing decision.

Contraindications

  • Systemic fungal infections (untreated) for systemic steroids.
  • Live vaccines with significant immunosuppression.
  • Hypersensitivity.
  • Topical: untreated skin infection at site (relative).

Precautions

  • Warnings For external use only Do not use • in the genital area if you have a vaginal discharge.
  • Consult a doctor. • for the treatment of diaper rash.
  • Consult a doctor.
  • When using this product • avoid contact with the eyes • do not use more than directed unless told to do so by a doctor • do not put directly into the rectum by using fingers or any mechanical device or applicator Stop use and ask a doctor if • condition worsens symptoms persist for more than 7 days or clear up and occur again within a few days, and do not begin use of any other hydrocortisone product unless you have asked a doctor • rectal bleeding occurs Keep out of reach of children.
  • If swallowed, get medical help or contact a Poison Control Center right away (1-800-222-1222).
02 Point of care

Dosing matrix

Population and organ-function guidance, shown together for faster comparison.

Adult

Directions • for itching of skin irritation, inflammation, and rashes: • adults and children 2 years of age and older: apply to affected area not more than 3 to 4 times daily • children under 2 years of age: do not use, ask a doctor • for external anal and genital itching, adults: • when practical, clean the affected area with mild soap and warm water and rinse thoroughly • gently dry by patting or blotting with toilet tissue or a soft cloth before applying • apply to affected area not more than 3 to 4 times daily • children under 12 years of age: ask a doctor

Paediatric

See label paediatric section if present; otherwise use paediatric formulary — do not extrapolate adult doses.

Renal

Fluid retention/hypertension — care in renal disease.

  • CrCl 0–120: Confirm renal dosing in product SmPC / primary label.
Hepatic

Prednisone needs hepatic activation to prednisolone.

03 Clinical use

Use, effects & interactions

Indications

Uses • temporarily relieves itching associated with minor skin irritations, inflammation, and rashes due to: • eczema • psoriasis • poison ivy, oak, sumac • insect bites • detergents • jewelry • cosmetics • soaps • seborrheic dermatitis • temporarily relieves external anal and genital itching • other uses of this product should only be under the advice and supervision of a doctor

Adverse effects

  • Insomnia, increased appetite, mood lability, dyspepsia, hyperglycaemia.
  • Chronic: cushingoid features, myopathy, osteoporosis, HPA suppression.
  • Topical: skin atrophy, striae.
  • Inhaled: thrush, dysphonia.
  • Fixed-dose/multi-ingredient product.
  • Clinical details partially inherited from component monographs: Hydrocortisone / Neomycin ear /eye drop, Neomycin / Gramicidin / Nystatin / Triamcinolone Acetonide.
  • Confirm combination SmPC for exact dosing.
04 Pharmacology

Mechanism & disposition

Corticosteroids bind intracellular glucocorticoid receptors, modulating gene transcription to suppress inflammatory cytokines, inhibit phospholipase A2 via lipocortins, reduce leukocyte migration and stabilise membranes — potent anti-inflammatory and immunosuppressive effects.

Corticosteroids bind intracellular glucoco…Mineralocorticoid activity varies by agent…
Read complete mechanism

Corticosteroids bind intracellular glucocorticoid receptors, modulating gene transcription to suppress inflammatory cytokines, inhibit phospholipase A2 via lipocortins, reduce leukocyte migration and stabilise membranes — potent anti-inflammatory and immunosuppressive effects. Mineralocorticoid activity varies by agent.

Onset

Hours–days

Duration

Agent and route dependent

Route

ORAL / IV / IM / INHALED / TOPICAL / NASAL / OPHTHALMIC

05 Special populations

Pregnancy, lactation & diet

Pregnancy

Used when maternal benefit clear; prefer agents with better obstetric data (e.g. prednisolone). Document risk–benefit.

Lactation

Low-dose systemic often compatible; time feeds if high dose — agent-specific.

06 Kenya market

Brands & loaded prices

From—
Median—
Listings0
BrandManufacturerPackObserved price
No reviewed brand listings are linked yet.
07 Provenance

Sources & review state

Primary sourceLocal active-ingredient clinical extract; FDA drug label via OpenFDA/DailyMed; Component monographs (multi-source pipeline); Professional class pharmacology (Corticosteroid)
Last reviewedNot recorded
EvidenceSource-linked
Open source document ↗

Decision support only. Confirm patient-specific decisions against the current product SmPC, Kenya STG/EML, and professional judgement.